As filed with the Securities and Exchange Commission
on September 27, 2021
Registration No. 333-_______
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-3
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
COMSOVEREIGN
HOLDING CORP.
(Exact Name of Registrant as Specified in Its Charter)
|
Nevada
|
|
46-5538504
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(IRS Employer
Identification Number)
|
5000 Quorum Drive, Suite 400
Dallas, TX 75254
(469) 930-2661
(Address, Including Zip Code, and Telephone Number,
Including Area Code, of Registrant’s Principal Executive Offices)
Daniel L. Hodges
5000 Quorum Drive, Suite 400
Dallas, TX 75254
(469) 930-2661
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)
Please send copies of all communications to:
|
Kevin Sherlock, Esq.
COMSovereign Holding Corp.
5000 Quorum Drive, Suite 400
Dallas, TX 75254
(469) 930-2661
|
Eric M. Hellige, Esq.
Pryor Cashman LLP
7 Times Square
New York, NY 10036
(212) 421-4100
|
Approximate
date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.
If the only securities being registered on this
form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐
If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, other than securities
offered only in connection with dividend or interest reinvestment plans, check the following box: ☒
If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment
filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. ☐
If this Form is a registration
statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with
the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
If this Form is a post-effective
amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional
classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate by check mark whether the registrant is
a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See
the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and
“emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
Large accelerated filer
|
|
☐
|
|
Accelerated filer
|
|
☐
|
|
|
|
Non-accelerated filer
|
|
☒
|
|
Smaller reporting company
|
|
☒
|
|
|
|
|
|
|
|
Emerging growth company
|
|
☐
|
|
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
CALCULATION OF REGISTRATION FEE
|
Title of Each Class of Securities to be Registered
|
|
Amount of Shares to be Registered (1)
|
|
|
Proposed
Maximum
Offering
Price per
Share
(2)
|
|
|
Proposed
Maximum
Aggregate
Offering
Price
|
|
|
Amount of
Registration
Fee
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, par value $0.0001 per share, issuable upon conversion of outstanding notes
|
|
|
5,600,001
|
(3)
|
|
$
|
1.70
|
|
|
$
|
9,520,001.70
|
|
|
$
|
1,038.64
|
|
|
Common Stock, $0.0001 par value per share, issuable upon exercise of outstanding warrants
|
|
|
3,135,789
|
(4)
|
|
$
|
1.70
|
|
|
$
|
5,330,841.30
|
|
|
$
|
581.59
|
|
|
Total
|
|
|
8,735,790
|
|
|
|
|
|
|
$
|
14,850,843.00
|
|
|
$
|
1,620.23
|
|
|
(1)
|
Pursuant to Rule 416 under the Securities Act of 1933, as amended, the shares of the Registrant’s common stock being registered hereunder include such indeterminate number of shares as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
|
|
|
|
|
(2)
|
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, as amended, based on the average of the high and low reported trading prices of the Registrant’s common stock as reported on the Nasdaq Capital Market on September 21, 2021.
|
|
|
|
|
(3)
|
Represents the maximum number of shares that the Registrant expects could be issuable upon conversion of the notes held by the selling stockholders named in this Registration Statement.
|
|
|
|
|
(4)
|
Represents the maximum number of shares that the Registrant expects could be issuable upon the exercise of warrants held by the selling stockholders named in this Registration Statement.
|
The Registrant hereby amends this Registration
Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which
specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Commission acting pursuant to
said Section 8(a) may determine.
The information in this prospectus is
not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange
Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities
in any state or other jurisdiction where the offer or sale is not permitted.
|
PRELIMINARY PROSPECTUS
|
|
SUBJECT TO COMPLETION
|
|
DATED SEPTEMBER
27, 2021
|
8,735,790 Shares
COMSovereign
Holding Corp.
This prospectus relates to the resale, from time
to time, by the selling stockholders named herein (the “Selling Stockholders”) of (i) an aggregate of 5,600,001 shares of
our common stock, par value $0.0001 per share, issuable upon the conversion of certain outstanding convertible promissory notes and (ii)
and aggregate of 3,135,789 shares of common stock issuable upon exercise of certain outstanding warrants (the “Warrants”).
We are not selling any securities under this prospectus
and we will not receive proceeds from the sale of the shares of our common stock by the Selling Stockholders. However, we may receive
proceeds from the cash exercise of the Warrants, which, if exercised in cash at the current applicable exercise price with respect to
all of the 3,135,789 shares of common stock, would result in gross proceeds to us of approximately $9.4 million.
We will pay the expenses of registering the shares
of common stock offered by this prospectus, but all selling and other expenses incurred by the Selling Stockholders will be paid by the
Selling Stockholders. The Selling Stockholders may sell our shares of common stock offered by this prospectus from time to time on terms
to be determined at the time of sale through ordinary brokerage transactions or through any other means described in this prospectus under
“Plan of Distribution.” The prices at which the Selling Stockholders may sell shares will be determined by the prevailing
market price for our common stock or in negotiated transactions.
Our common stock is quoted on The Nasdaq Capital
Market, or Nasdaq, under the symbol “COMS.” On September 24, 2021, the last reported sale price for our common stock on Nasdaq
was $1.85.
Investing in our securities involves a
high degree of risk. See “Risk Factors” beginning on page 7 of this prospectus for a discussion of information that
should be considered in connection with an investment in our securities.
Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.
The date of this prospectus is ,
2021.
TABLE OF CONTENTS
ABOUT THIS PROSPECTUS
This prospectus is part of
a registration statement on Form S-3 that we filed with the U.S. Securities and Exchange Commission (the “SEC”). You
should read this prospectus and the information and documents incorporated herein by reference carefully. Such documents contain
important information you should consider when making your investment decision. See “Where You Can Find Additional
Information” and “Incorporation of Certain Documents by Reference” in this prospectus.
You should rely only on the information
contained in or incorporated by reference into this prospectus. Neither we nor the selling stockholders named herein (the
“Selling Stockholders”) have authorized anyone to provide you with information different from, or in addition to, that
contained in or incorporated by reference into this prospectus. This prospectus is an offer to sell only the securities offered
hereby but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in or incorporated
by reference into this prospectus is current only as of their respective dates or on the date or dates that are specified in those
documents. Our business, financial condition, results of operations and prospects may have changed since those dates.
The Selling Stockholders are not offering to sell
or seeking offers to purchase these securities in any jurisdiction where the offer or sale is not permitted. Neither we nor the Selling
Stockholders have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where
action for that purpose is required, other than in the United States. Persons outside the jurisdiction of the United States who come into
possession of this prospectus are required to inform themselves about and to observe any restrictions relating to this Offering and the
distribution of this prospectus applicable to that jurisdiction.
If required, each time the Selling Stockholders
offer shares of common stock, we will provide you with, in addition to this prospectus, a prospectus supplement that will contain specific
information about the terms of that offering. We may also authorize the Selling Stockholders to use one or more free writing prospectuses
to be provided to you that may contain material information relating to that offering. We may also use a prospectus supplement and any
related free writing prospectus to add, update or change any of the information contained in this prospectus or in documents we have
incorporated by reference. This prospectus, together with any applicable prospectus supplements, any related free writing prospectuses
and the documents incorporated by reference into this prospectus, includes all material information relating to this offering. To the
extent that any statement that we make in a prospectus supplement is inconsistent with statements made in this prospectus, the statements
made in this prospectus will be deemed modified or superseded by those made in a prospectus supplement. Please carefully read both this
prospectus and any prospectus supplement together with the additional information described below under the section entitled “Incorporation
of Certain Documents by Reference” before buying any of the securities offered.
Unless the context otherwise requires, the terms
“ our company,” “we,” “us” and “our” refer to COMSovereign Holding Corp. and our subsidiaries.
Unless otherwise indicated, information contained
in this prospectus or incorporated by reference herein concerning our industry and the markets in which we operate is based on information
from independent industry and research organizations, other third-party sources (including industry publications, surveys and forecasts),
and management estimates. Management estimates are derived from publicly available information released by independent industry analysts
and third-party sources, as well as data from our internal research, and are based on assumptions made by us upon reviewing such data
and our knowledge of such industry and markets, which we believe to be reasonable. Although we believe the data from these third-party
sources is reliable, we have not independently verified any third-party information. In addition, projections, assumptions and estimates
of the future performance of the industry in which we operate and our future performance are necessarily subject to uncertainty and risk
due to a variety of factors, including those described in “Risk Factors” and “Cautionary Note Regarding Forward-Looking
Statements.” These and other factors could cause results to differ materially from those expressed in the estimates made by the
independent parties and by us.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
When used in this prospectus, including the documents
that we have incorporated by reference, in future filings with the SEC or in press releases or other written or oral communications, statements
which are not historical in nature, including those containing words such as “believe,” “expect,” “anticipate,”
“estimate,” “plan,” “continue,” “intend,” “should,” “may” or the
negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which
do not relate solely to historical matters, are intended to identify “forward-looking statements” within the meaning of the
Private Securities Litigation Reform Act of 1995 (set forth in Section 27A of the Securities Act of 1933, as
amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”)). In particular, statements pertaining to our trends, liquidity and capital resources, among others,
contain forward-looking statements. You can also identify forward-looking statements by discussions of strategy, plans or intentions.
Examples of forward-looking statements include, but are not limited to, statements about the following:
|
|
●
|
our prospects, including our future business, revenues, expenses,
net income, earnings per share, gross margins, profitability, cash flows, cash position, liquidity, financial condition and results of
operations, backlog of orders and revenue, our targeted growth rate, our goals for future revenues and earnings, and our expectations
about realizing the revenues in our backlog and in our sales pipeline;
|
|
|
●
|
the potential impact of COVID-19 on our business and results of
operations;
|
|
|
●
|
the effects on our business, financial condition and results of
operations of current and future economic, business, market and regulatory conditions, including the current economic and market conditions
and their effects on our customers and their capital spending and ability to finance purchases of our products, services, technologies
and systems;
|
|
|
●
|
the effects of fluctuations in sales on our business, revenues,
expenses, net income, earnings per share, margins, profitability, cash flows, capital expenditures, liquidity, financial condition and
results of operations;
|
|
|
●
|
our products, services, technologies and systems, including their
quality and performance in absolute terms and as compared to competitive alternatives, their benefits to our customers and their ability
to meet our customers’ requirements, and our ability to successfully develop and market new products, services, technologies and
systems;
|
|
|
●
|
our markets, including our market position and our market
share;
|
|
|
●
|
our ability to successfully develop, operate, grow and diversify
our operations and businesses;
|
|
|
●
|
our business plans, strategies, goals and objectives, and
our ability to successfully achieve them;
|
|
|
●
|
the sufficiency of our capital resources, including our cash
and cash equivalents, funds generated from operations, availability of borrowings under our credit and financing arrangements and other
capital resources, to meet our future working capital, capital expenditure, lease and debt service and business growth needs;
|
|
|
●
|
the value of our assets and businesses, including the revenues,
profits and cash flows they are capable of delivering in the future;
|
|
|
●
|
the effects on our business operations, financial results,
and prospects of business acquisitions, combinations, sales, alliances, ventures and other similar business transactions and relationships;
|
|
|
●
|
industry trends and customer preferences and the demand for
our products, services, technologies and systems; and
|
|
|
●
|
the nature and intensity of our competition, and our ability
to successfully compete in our markets.
|
These statements are necessarily subjective, are
based upon our current plans, intentions, objectives, goals, strategies, beliefs, projections and expectations, and involve known and
unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry
results, to differ materially from any future results, performance or achievements described in or implied by such statements. Actual
results may differ materially from expected results described in our forward-looking statements, including with respect to correct measurement
and identification of factors affecting our business or the extent of their likely impact, the accuracy and completeness of the publicly-available
information with respect to the factors upon which our business strategy is based, or the success of our business.
Forward-looking statements should not be read as
a guarantee of future performance or results and will not necessarily be accurate indications of whether, or the times by which, our performance
or results may be achieved. Forward-looking statements are based on information available at the time those statements are made and management’s
belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or
results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that may cause
actual results, our performance or achievements, or industry results to differ materially from those contemplated by such forward-looking
statements include, without limitation, those discussed under the caption “Risk Factors” in this prospectus as well as other
risks and factors identified from time to time in our SEC filings.
PROSPECTUS SUPPLEMENT SUMMARY
This summary highlights information
contained elsewhere or incorporated by reference in this prospectus. This summary is not complete and does not contain all of the information
that you should consider before investing in our common stock. We urge you to read this entire prospectus and the documents incorporated
by reference herein carefully, including the financial statements and notes to those financial statements incorporated by reference herein
and therein. Please read the section of this prospectus entitled “Risk Factors” for more information about important risks
that you should consider before investing in our common stock.
Our Company
We are a provider of technologically-advanced telecom
solutions to network operators, mobile device carriers, governmental units and other enterprises worldwide. We have assembled a portfolio
of communications, power and portable infrastructure technologies, capabilities and products that enable the upgrading of latent 3G networks
to 4G and 4G-LTE networks and will facilitate the rapid roll out of the 5G and “next-Generation” (“nG”) networks
of the future. We focus on novel capabilities, including signal modulations, antennae, software, hardware and firmware technologies that
enable increasingly efficient data transmission across the electromagnetic spectrum. Our product solutions are complemented by a broad
array of services, including technical support, systems design and integration, and sophisticated research and development programs. While
we compete globally on the basis of our innovative technology, the breadth of our product offerings, our high-quality cost-effective customer
solutions, and the scale of our global customer base and distribution, our primary focus is on the North American telecom infrastructure
and service market. We believe we are in a unique position to rapidly increase our near-term domestic sales as we are among the few U.S.-based
providers of telecommunications equipment and services.
We provide the following categories of product
offerings and solutions to our customers:
|
|
●
|
Telecom and Network Products and Solutions. We design, develop, market and sell technologically-advanced products for telecom network operators, mobile device carriers and other enterprises, including the following:
|
|
|
●
|
Backhaul Telecom Radios. We offer a line of high-capacity packet microwave solutions that drive next-generation IP networks. Our carrier-grade point-to-point packet microwave systems transmit broadband voice, video and data. Our solutions enable service providers, government agencies, enterprises and other organizations to meet their increasing bandwidth requirements rapidly and affordably. The principal application of our product portfolio is wireless network transport, including a range of products ideally suited to support the emergence of underlying small cell networks. Additional solutions include leased-line replacement, last mile fiber extension and enterprise networks.
|
|
|
●
|
In-Band Full-Duplex Technologies. We have developed
proprietary wireless transmission technologies that alleviate the performance limitations of the principal transmission technologies
used by most networks today. Time Division Duplex ("TDD") transmission technology used by many communications systems
utilizes a single channel for transmission of data alternating between downlink or uplink, which limits capacity/throughput.
Frequency Division Duplex ("FDD") technologies in the marketplace today use two independent channels for downlink and
uplink but require twice the spectrum. Neither TDD nor FDD can simultaneously transmit and receive on a single channel — a
limitation that network advancements and 5G will require for optimal performance. In late 2021, we intend to commence marketplace
demonstrations of products incorporating our proprietary In-Band Full-Duplex technologies that simultaneously transmit and receive
data on a single channel, which resolves the limitation of current TDD and FDD transmissions by increasing network performance and
doubling spectrum efficiency. We intend to begin commercializing this technology in the first half of 2022.
|
|
|
●
|
Edge Compute Capable Small Cell 4G LTE and 5G Access Radios. We offer Citizens Broadband Radio Service frequency and other small
cell radios that are designed to connect to other access radios or to connect directly to mobile devices such as mobile phones and other
Internet of things ("IoT") devices. Recently, we developed what we believe is the world’s first fully-virtualized 5G core
network on a microcomputer the size of a credit card, enabling, for the first time, the ability to have the 5G network collocated on the
network edge with the small cell communicating with the devices themselves. The small cells support edge-based application hosting and
enable third-party service integration.
|
|
|
●
|
Intelligent Batteries and Back-Up Power Solutions. We are developing for the telecom industry a full line of environmentally-friendly,
non-volatile advanced intelligent lithium-ion batteries and back-up power units that charge quickly, have a life span approximately five
times longer than conventional lead-acid batteries, and can be monitored remotely. We are also currently offering and developing models
that provide power for a wide range of applications, including cellular towers and other radio access network infrastructures, automobiles,
boats, spacecraft and other vehicles.
|
|
|
●
|
Tethered Drones and Aerostats. We design, manufacture, sell and provide logistical services for specialized
tethered aerial monitoring and communications platforms serving national defense and security customers for use in applications such as
intelligence, surveillance and reconnaissance (“ISR”) and communications. We focus primarily on a suite of tethered aerostats
known as the Winch Aerostat Small Platform, which are principally designed for military and security applications and provide secure and
reliable aerial monitoring for extended durations while being tethered to the ground via a high-strength armored tether. Our recently-acquired
HoverMast line of quadrotor-tethered drones feature uninterruptible ground-based power, fiber optic communications for cyber immunity,
and the ability to operate in GPS-denied environments while delivering dramatically-improved situational awareness and communications
capabilities to users.
|
We are also developing processes that we believe
will significantly advance the state-of-the-art in silicon photonic (SiP) devices for use in advanced data interconnects, communication
networks and computing systems. We believe our novel approach will allow us to overcome the limitations of current SiP modulators, dramatically
increase computing bandwidth and reduce drive power while offering lower operating costs.
Our engineering and management teams have extensive experience in optical
systems and networking, digital signal processing, large-scale application-specific integrated circuit design and verification, SiP design
and integration, system software development, hardware design, high-speed electronics design and network planning, installation, maintenance
and servicing. We believe this broad expertise in a wide range of advanced technologies, methodologies and processes enhances our innovation,
design and development capabilities, and has enabled us, and we believe will continue to enable us, to develop and introduce future-generation
communications and computing technologies. In the course of our product development cycles, we engage with our customers as they design
their current and next-generation network equipment in order to gauge current and future market needs.
Our more than 700 customers include a majority of the leading global
telecommunication operators, as well as many data center managers and leading multi-system operators, and hundreds of enterprise customers,
including many Fortune 500 companies. We have long-standing, direct relationships with our customers and serve them through a direct sales
force and a global network of channel partners.
Our Operating Units
Through a series of acquisitions, we and our operating subsidiaries
have expanded our service offerings and geographic reach over the past three years. On November 27, 2019, we completed the acquisition
of ComSovereign Corp. (“ComSovereign”) in a stock-for-stock transaction with a total purchase price of approximately $80 million
(the “ComSovereign Acquisition”). ComSovereign had been formed in January 2019 and, prior to its acquisition by our company,
had completed five acquisitions of companies with unique products in development for, or then being marketed to, the telecommunications
market. As a result of our acquisitions, our company is comprised of the following principal operating units, each of which was acquired
to address a different opportunity or sector of the North American telecom infrastructure and service market. Our subsidiary holdings
are held in three divisions, Telecoms, Drone, and Power.
Our Telecoms Division is comprised of the following
principal operating units:
|
|
●
|
DragonWave-X LLC. DragonWave-X, LLC and its operating subsidiaries, DragonWave Corp. and DragonWave-X Canada, Inc. (collectively, “DragonWave”), are a Dallas-based manufacturer of high-capacity microwave and millimeter wave point-to-point telecom backhaul radio units. DragonWave and its predecessor have been selling telecom backhaul radios since 2012 and its microwave radios have been installed in over 330,000 locations in more than 100 countries worldwide. According to a report of the U.S. Federal Communications Commission, as of December 2019, DragonWave was the second largest provider of licensed point-to-point microwave backhaul radios in North America. DragonWave was acquired by ComSovereign in April 2019 prior to the ComSovereign Acquisition.
|
|
|
●
|
Virtual Network Communications Inc. Virtual Network Communications Inc. (“VNC”) is an edge compute focused wireless telecommunications technology developer and equipment manufacturer of both 4G LTE Advanced and 5G capable radio equipment. VNC designs, develops, manufactures, markets, and supports a line of network products for wireless network operators, mobile virtual network operators, cable TV system operators, and government and business enterprises that enable new sources of revenue, and reduce capital and operating expenses. VNC also has developed rapidly deployable, tactical systems that can be combined with the tethered aerostats and drones offered by our Drone Aviation subsidiary and enabled and operated in nearly any location in the world. We acquired VNC in July 2020.
|
|
|
●
|
Fastback. Skyline Partners Technology LLC, which does business under the name
Fastback Networks (“Fastback”), is a manufacturer of intelligent backhaul radio (IBR) systems that deliver high-performance
wireless connectivity to virtually any location, including those challenged by Non-Line of Sight limitations. Fastback’s advanced
IBR products allow operators to economically add capacity and density to their macrocells and expand service coverage density with small
cells. These solutions also allow operators to both provide temporary cellular and data service utilizing mobile/portable radio systems
and provide wireless Ethernet connectivity. We acquired Fastback in January 2021.
|
|
|
|
|
|
|
●
|
Silver Bullet Technology, Inc. Silver Bullet Technology, Inc. (“Silver Bullet”) is a California-based engineering firm that designs and develops next generation network systems and components, including large-scale network protocol development, software-defined radio systems and wireless network designs. ComSovereign acquired Silver Bullet in March 2019 prior to the ComSovereign Acquisition.
|
|
|
|
|
|
|
●
|
Lextrum, Inc. Lextrum, Inc. (“Lextrum”) is a Tucson, Arizona-based developer of full-duplex wireless technologies and components, including multi-reconfigurable radio frequency (RF) antennae and software programs. This technology enables the doubling of a given spectrum band by allowing simultaneous transmission and receipt of radio signals on the same frequencies. ComSovereign acquired Lextrum in April 2019 prior to the ComSovereign Acquisition.
|
|
|
|
|
|
|
●
|
Innovation Digital, LLC. Innovation Digital, LLC (“Innovation Digital”) is a California-based
developer of "beyond state-of-the-art" mixed analog/digital signal processing solutions, intellectual property (IP) licensing,
design and consulting services. Its signal processing techniques and intellectual property have significantly enhanced the bandwidth and
accuracy of RF transceiver systems and have provided enabling technologies in the fields of communications and RADAR systems, signals
intelligence and electronic warfare (EW), test and measurement systems, and semiconductor devices. We acquired Innovation Digital in June
2021.
|
|
|
|
|
|
|
●
|
VEO Photonics, Inc. VEO Photonics, Inc. (“VEO”), based in San Diego, California, is a research and development company innovating SiP technologies for use in copper-to-fiber-to-copper switching, high-speed computing, high-speed ethernet, autonomous vehicle applications, mobile devices and 5G wireless equipment. ComSovereign acquired VEO in January 2019 prior to the ComSovereign Acquisition.
|
|
|
●
|
RF Engineering & Energy Resource, LLC. RF Engineering & Energy Resource, LLC ("RF Engineering”)
is a Michigan-based provider of high-quality microwave antennas and accessories. By providing one of the industry's lowest cost of ownership,
RF Engineering has continued to innovate and expand, and it announced the industry's first Universal Licensed Microwave Antenna. Supporting
frequencies from (6-42 GHz), customers can now reduce sparing costs and safely future-proof their networks by leveraging this new Universal
plug and play architecture. We acquired RF Engineering in July 2021.
|
Our Drone Division is comprised of the following
principal operating units:
|
|
●
|
Drone Aviation. Lighter Than Air Systems Corp., which does business under the name
Drone Aviation (“Drone Aviation”), is based in Jacksonville, Florida and develops and manufactures cost-effective, compact
and enhanced tethered unmanned aerial vehicles, including Lighter-Than-Air aerostats and drones that support surveillance sensors and
communications networks. We acquired Drone Aviation in June 2014.
|
|
|
●
|
Sky Sapience Ltd. Sky Sapience Ltd. (“SKS”) is an Israeli-based manufacturer
of drones with a patented tethered hovering technology that provides long-duration, mobile and all-weather ISR capabilities to customers
worldwide for both land and marine-based applications. Its innovative technologies include fiber optic tethers that enable secure, high-capacity
communications, including support for commercial 4G and 5G wireless networks. SKS’s flagship HoverMast line of quadrotor-tethered
drones feature uninterruptible ground-based power, fiber optic communications for cyber immunity, and the ability to operate in GPS-denied
environments while delivering dramatically-improved situational awareness and communications capabilities to users. We acquired SKS
in March 2021.
|
|
|
●
|
RVision, Inc. RVision Inc. (“RVision”) is a California-based developer of technologically-advanced video and communications products and physical security solutions designed for government and private sector commercial industries. It has been serving governments and the military for nearly two decades with sophisticated, environmentally-rugged optical and infrared cameras, hardened processors, custom tactical video hardware, software solutions, and related communications technologies. It also has developed nano-defractive optics with integrated, artificial intelligence-driven electro-optical sensors and communication network connectivity products for smart city/smart campus applications. We acquired RVision in April 2021.
|
Our Power Division is comprised of the following
principal operating units:
|
|
●
|
InduraPower, Inc. InduraPower Inc. (“InduraPower”) is a Tucson, Arizona-based developer and manufacturer of intelligent batteries and back-up power supplies for network systems and telecom nodes. It also provides power designs and batteries for the aerospace, marine and automotive industries. ComSovereign acquired InduraPower in January 2019 prior to the ComSovereign Acquisition.
|
|
|
●
|
Sovereign Plastics LLC. Sovereign Plastics LLC (“Sovereign Plastics”), based in Colorado Springs, Colorado, operates as the material, component manufacturing and supply chain source for all of our subsidiaries, and also provides plastic and metal components to third-party manufacturers. Its ability to rapidly prototype new product offerings and machine moldings, metals and plastic castings has reduced the production cycle for many of our components from months to days. We acquired the business currently conducted by Sovereign Plastics in March 2020.
|
Risks Associated With Our Business
Our ability to execute our business strategy is subject to numerous
risks, as more fully described in the section captioned “Risk Factors” immediately following this prospectus summary. You
should read these risks before you invest in our securites. In particular, risks associated with our business include, but are not limited
to, the following:
|
|
●
|
Since our recent acquisition of ComSovereign in November 2019,
we lack an established operating history on which to evaluate our consolidated business and determine if we will be able to execute our
business plan, and we can give no assurance that our operations will result in profits.
|
|
|
●
|
We incurred net losses in our fiscal years ended December 31,
2020 and 2019 with negative cash flows, and we cannot assure you as to when, or if, we will become profitable and generate positive cash
flows.
|
|
|
●
|
We expect to continue to incur losses from operations and
negative cash flows, which raise substantial doubt about our ability to continue as a going concern.
|
|
|
●
|
We may not generate sufficient cash flows to cover our operating
expenses.
|
|
|
●
|
We have significant debt and if we are unable to repay our
debt when it becomes due, our business, financial condition and results of operations could be materially harmed.
|
|
|
●
|
If we are unable to obtain additional funding when needed,
our business operations will be harmed, and if we do obtain additional financing, our then-existing stockholders may suffer substantial
dilution.
|
|
|
●
|
Raising capital in the future could cause dilution to our
existing stockholders and may restrict our operations or require us to relinquish rights.
|
|
|
●
|
The COVID-19 pandemic may negatively affect our operations
depending on the severity and longevity of the pandemic.
|
|
|
●
|
Rapid technological change in our market and/or changes in
customer requirements could cause our products to become obsolete or require us to redesign our products, which would have a material
adverse effect on our business, operating results and financial condition.
|
|
|
●
|
Product development is a long, expensive and uncertain process,
and our failure to develop marketable products in our various markets could adversely affect our business, prospects and financial condition.
|
|
|
●
|
We compete with companies that have significantly more resources
for their research and development efforts than we have or have received government contracts for the development of new products.
|
|
|
●
|
Product quality problems, defects, errors or vulnerabilities
in our products could harm our reputation and adversely affect our business, financial condition, results of operations and prospects.
|
|
|
●
|
If we lose our rights to use software we currently license
from third parties, we could be forced to seek alternative technology, which could increase our operating expenses and could adversely
affect our ability to compete.
|
|
|
●
|
If sufficient radio spectrum is not allocated for use by our
products or if we fail to obtain regulatory approval for our products, our ability to market our products may be restricted.
|
|
|
●
|
If critical components or raw materials used to manufacture
our products become scarce or unavailable, then we may incur delays in manufacturing and delivery of our products, which could damage
our business.
|
|
|
●
|
Our future profitability may depend on achieving cost reductions
from increasing manufacturing quantities of our products. Failing to achieve such reductions in manufacturing costs could materially
affect our business.
|
|
|
●
|
Our potential customers for our DragonWave radios and our
Drone Aviation aerostat and drone products are likely to include U.S. Government or Government-related entities that are subject
to appropriations by Congress. Reduced funding for defense procurement and research and development programs would likely adversely impact
our ability to generate revenues.
|
|
|
●
|
We may be unable to successfully integrate our recent and
future acquisitions, which could adversely affect our business, financial condition, results of operations and prospects.
|
|
|
●
|
There may be health and safety risks relating to wireless
products.
|
|
|
●
|
If a successful product liability claim were made against
us, our business could be seriously harmed.
|
|
|
●
|
Our tethered aerostat and drone business and operations are
subject to the risks of hurricanes, tropical storms, and other natural disasters.
|
Our Corporate Information
We were incorporated as Drone Aviation Holding
Corp. in the State of Nevada on April 17, 2014. An amendment to our Articles of Incorporation changing our name to COMSovereign Holding
Corp. was effected on November 30, 2019. Our principal executive offices are located at 5000 Quorum Drive, Suite 400, Dallas, Texas 75254,
and our telephone number is (469) 930-2661. Our website address is www.COMSovereign.com, and many of our subsidiaries also have
their own websites linked to and that may be accessed from our principal corporate website. Information on our website and on that of
our subsidiaries is not part of this prospectus.
The Offering
|
Securities offered by the Selling Stockholders:
|
|
8,735,790 shares of common stock, which includes (i) 5,600,001 shares
of common stock issuable upon the conversion of outstanding convertible promissory notes (the “Notes”), and (ii) 3,135,789
shares of common stock issuable upon the exercise of outstanding warrants to purchase shares of common stock (the “Warrants”).
|
|
|
|
|
|
Common stock outstanding:
|
|
72,533,850 shares
|
|
|
|
|
|
Common stock to be outstanding after the offering
assuming conversion of all of the Notes and exercise of all Warrants:
|
|
81,269,640 shares
|
|
|
|
|
|
Use of Proceeds:
|
|
We will not receive any proceeds from the sale by the Selling Stockholders
of the shares of common stock being offered by this prospectus. However, we may receive proceeds from the cash exercise of the Warrants,
which, if exercised in cash at the current exercise price with respect to all Warrants, would result in gross proceeds to us of approximately
$9.4 million. The proceeds from such Warrant exercises, if any, will be used for working capital and general corporate purposes.
|
|
|
|
|
|
Risk Factors:
|
|
Investing in our securities is highly speculative and involves a high degree of risk. You should
carefully consider the information set forth in the “Risk Factors” section on page 7 before
deciding to invest in our securities.
|
|
|
|
|
|
Trading Symbol:
|
|
Our common stock is currently quoted on The Nasdaq Capital Market under the trading symbol “COMS”.
|
The shares of common stock outstanding and the
shares of common stock to be outstanding after this offering is based on 72,533,850 shares outstanding as of September 20, 2021 and excludes
an aggregate of up to approximately 16,290,977 shares of common stock based upon the following:
|
|
●
|
An aggregate of 8,555,804 shares of common stock issuable upon the
exercise of stock purchase warrants outstanding as of September 20, 2021 with a weighted average exercise price of $4.20 per share that
expire between November 9, 2021 and January 10, 2026;
|
|
|
●
|
An aggregate of 2,391,335 shares of common stock issuable upon the
conversion of convertible indebtedness outstanding as of September 20, 2021 with a weighted average conversion price of $4.91 per share
that mature between June 6, 2021 and January 29, 2026; and
|
|
|
●
|
An aggregate of 7,868,848 shares of common stock issuable upon the
exercise of options outstanding as of September 20, 2021 with a weighted average exercise price of $2.247 per share granted under our long-term
equity incentive plans.
|
RISK FACTORS
An investment in our securities involves a number
of risks. Before deciding to invest in our securities, you should carefully consider the risks described below and discussed under the
section captioned “Risk Factors” contained in our Annual Report on Form 10-K for the year ended December 31, 2020, our Quarterly
Report on Form 10-Q for the three-month period ended March 31, 2021 and our Quarterly Report on Form 10-Q for the three-and six-month
periods ended June 30, 2021, which are incorporated by reference in this prospectus, the information and documents incorporated by reference
herein, and in any prospectus supplement or free writing prospectus that we have authorized for use in connection with an offering. If
any of these risks actually occurs, our business, financial condition, results of operations or cash flow could be harmed. This could
cause the trading price of our common stock to decline, resulting in a loss of all or part of your investment. The risks described in
the documents referenced above are not the only risks that we face. Additional risks not presently known to us or that we currently deem
immaterial may also affect our business.
ISSUANCE OF SECURITIES TO SELLING STOCKHOLDERS
We issued all of the Notes and the Warrants in
2021 in connection with the following transactions:
May 2021 Private Placement..
On May 27, 2021, we entered into a securities purchase agreement (the “May Purchase Agreement”) with Lind Global Asset Management
IV, LLC (the “Initial Investor”), pursuant to which we sold to the Initial Investor a senior secured convertible promissory
note in the original principal amount of $11,000,000 (the “May Note”) and warrants (the “May Warrants”) to purchase
up to 1,820,000 shares of our common stock for a purchase price of $10,000,000 (representing an original issue discount of 10.0% on the
Initial Note), of which $5,000,000 was paid on May 28, 2021 and $5,000,000 was paid on June 2, 2021.
The May Note bears interest
at the rate of 6% per annum from the date of funding and matures on May 27, 2023. We were originally required to make monthly interest
payments commencing six months after the date of issuance of the May Note and principal payments in 18 equal monthly installments of
$611,111 each, commencing six months after the date of issuance of the May Note. So long as shares of our common stock are registered
for resale under the Securities Act or may be sold without restriction on the number of shares or manner of sale, we have the right
to make interest and principal payments in the form of additional shares of common stock, which shares will be valued at 90% of the average
of the five lowest daily volume weighted average price per share of the common stock during the ten trading days immediately preceding
the date of issuance of such shares of common stock (the “Repayment Share Price”); provided, however, that with respect to
the first interest payment, the holder of the May Note has the right to direct that the payment of such interest be made in shares of
our common stock.
The May Note is convertible by the holder in whole
or in part at any time after the six-month anniversary of the issuance date into shares of our common stock, originally at a conversion
price of $4.50 per share, subject to adjustment. However, the holder of the May Note will not have the right to convert any portion of
the May Note if the holder, together with its affiliates, would beneficially own in excess of 4.99% of the number of shares of our common
stock outstanding immediately after giving effect to its conversion and under no circumstances may convert the May Note if the holder,
together with its affiliates, would beneficially own in excess of 9.99% of the number of shares of common stock outstanding immediately
after giving effect to its conversion. We have the right to prepay the May Note at any time with no penalty (the “Buy-Back Right”).
However, should we exercise our Buy-Back Right, the holder of the May Note will have the option of converting 25% of the outstanding principal
amount of the May Note into shares of common stock at a conversion price equal to the lower of (A) the Repayment Price, or (B) the conversion
price then in effect.
The May Note is guaranteed
by each of our subsidiaries and is secured by a first priority lien on all of our assets and properties and the assets and properties
of our subsidiaries, subject only to the mortgage lien on our manufacturing facility in Tucson, Arizona and the liens securing approximately
$1 million principal amount of outstanding indebtedness of one of our subsidiaries.
The May Warrants are exercisable to purchase up
to 1,820,000 shares of common stock, originally for a purchase price of $4.50 per share, subject to adjustment, at any time on or prior
to May 27, 2026, and may be exercised on a cashless basis if the shares of our common stock underlying the Warrants are not then registered
under the Securities Act. The May Warrants have the same exercise limitation as is included in the May Note.
August
2021 Private Placement. On August 25, 2021, we entered into a securities purchase agreement (the “August
Purchase Agreement”) with Lind Global Fund II LP (the “Lind Global Fund”), pursuant to which we sold to Lind Global
Fund a senior secured convertible promissory note in the original principal amount of $5,800,000 (the “August Note”) and
warrants (the “August Warrants”) to purchase up to 1,315,789 shares of our common stock for a purchase price of $5,000,000
(representing an original issue discount of 16.0% on the August Note), which $5,000,000 was paid on August 26, 2021.
The
August Note bears interest at the rate of 6% per annum from the date of funding and matures on August 25, 2023. We are required to make
monthly payments commencing five business days after the date the registration statement of which this prospectus is a part is declared
effective by the SEC, but in no event later than November 30, 2021, and principal payments in 18 equal monthly installments of $322,222
each. So long as shares of our common stock are registered for resale under the Securities Act or may be sold without restriction
on the number of shares or manner of sale, we have the right to make interest and principal payments in the form of additional shares
of common stock, which shares will be valued at the Repayment Share Price; provided, however, that with respect to the first interest
payment, Lind Global Fund has the right to direct that the payment of such interest be made in shares of our common stock.
The August Note is convertible
by the holder in whole or in part at any time at a conversion price of $3.00 per share, subject to adjustment. However, the holder of
the Note will not have the right to convert any portion of the Note if the holder, together with its affiliates, would beneficially own
in excess of 4.99% of the number of shares of our Common Stock outstanding immediately after giving effect to its conversion and under
no circumstances may convert the Note if the holder, together with its affiliates, would beneficially own in excess of 9.99% of the number
of shares of Common Stock outstanding immediately after giving effect to its conversion. We have the right to prepay the August Note
at any time with no penalty; however, should we exercise such right, the holder of the August Note will have the option of converting
33 1/3% of the outstanding principal amount of the August Note into shares of our common stock at a conversion price equal to the lower
of (A) the Repayment Share Price, or (B) the conversion price then in effect.
The
August Note is guaranteed by each of our subsidiaries and is secured by a first priority lien on all of our assets and properties and
substantially all of the assets and properties of our subsidiaries.
The August Warrants are exercisable
to purchase up to 1,315,789 shares of our common stock for a purchase price of $3.00 per share, subject to adjustment, at any time on
or prior to August 25, 2026, and may be exercised on a cashless basis if the shares of common stock underlying the August Warrants are
not then registered under the Securities Act. The August Warrants have the same exercise limitation as is included in the August
Note.
On August 25, 2021, in connection with the transactions
contemplated by the August Purchase Agreement, we entered into an amendment to the May Purchase Agreement to, among other matters, permit
the transactions contemplated by the August Purchase Agreement, including the grant to Lind Global Fund of a pro rata security interest
in the assets we pledged to secure May Note, and to amend the registration rights granted thereunder to coincide with the registration
rights we granted under the August Purchase Agreement. In addition, on August 25, 2021, in connection with such transactions, we also
amended the May Note to reduce the initial conversion price of such note to $3.00 per share and to accelerate the initial conversion
date of such note to coincide with the initial conversion date of the August Note. The May Warrants also have been adjusted to a purchase
price of $3.00 per share.
The August Note is guaranteed by each of our subsidiaries
and is secured by a first priority lien on all of our assets and properties and the assets and properties of our subsidiaries, subject
only to the mortgage lien on our manufacturing facility in Tucson, Arizona and the liens securing approximately $1 million principal amount
of outstanding indebtedness of one of our subsidiaries.
Pursuant to the May and August Notes, subject to certain exceptions, if
we issue shares of our preferred stock, unless otherwise waived in writing by the holders of the Notes, we will be required to use the
proceeds of such issuance to repay the Notes. If we issue any equity interests for aggregate proceeds of greater than $20,000,000, excluding
offering costs or other expenses, we will be required to direct 20% of such proceeds from such issuance to repay the Notes.
USE OF PROCEEDS
We are not selling any securities under this prospectus
and will not receive any proceeds from the sale of the common stock offered by this prospectus by the Selling Stockholders. However,
we may receive proceeds from the cash exercise of the Warrants, which, if exercised in cash at the current exercise price with respect
to all Warrants, would result in gross proceeds to us of approximately $9.4 million. The proceeds from such Warrant exercises, if any,
will be used for working capital and general corporate purposes. We cannot predict when or whether the Warrants will be exercised, and
it is possible that some or all of the Warrants may expire unexercised. For information about the Selling Stockholders, see “Selling
Stockholders.”
The Selling Stockholders will pay any underwriting
discounts and commissions and expenses incurred by the Selling Stockholders for brokerage or legal services or any other expenses incurred
by the Selling Stockholders in disposing of the shares of common stock offered hereby. We will bear all other costs, fees and expenses
incurred in effecting the registration of the shares of common stock covered by this prospectus, including all registration and filing
fees and fees and expenses of our counsel and accountants.
DESCRIPTION OF SECURITIES
Our authorized capital stock consists of 300,000,000 shares of common
stock, par value $0.0001 per share, and 100,000,000 shares of preferred stock, par value $0.0001 per share. As of September 20, 2021,
72,533,850 shares of common stock are issued and outstanding and no shares of preferred stock are issued and outstanding. In addition,
as of such date, 11,691,593 shares of common stock were reserved for issuance upon the exercise of outstanding common stock purchase warrants,
7,868,848 shares of common stock were reserved for issuance upon the exercise of outstanding common stock purchase options, and 2,391,335
shares of common stock were reserved for issuance upon the conversion of outstanding convertible debt incurred in conjunction with the
Fastback and Innovation Digital acquisitions.
Common Stock
Voting, Dividend and Other Rights. Each
outstanding share of common stock entitles the holder to one vote on all matters presented to the shareholders for a vote. Holders of
shares of common stock have no cumulative voting, pre-emptive, subscription or conversion rights. All shares of common stock to be issued
pursuant to this registration statement will be duly authorized, fully paid and non-assessable. Our board of directors determines if
and when distributions may be paid out of legally available funds to the holders. To date, we have not declared any dividends with respect
to our common stock. Our declaration of any cash dividends in the future will depend on our board of directors’ determination as
to whether, in light of our earnings, financial position, cash requirements and other relevant factors existing at the time, it appears
advisable to do so. We do not anticipate paying cash dividends on the common stock in the foreseeable future.
Rights Upon Liquidation. Upon
liquidation, subject to the right of any holders of the preferred stock to receive preferential distributions, each outstanding share
of common stock may participate pro rata in the assets remaining after payment of, or adequate provision for, all our known debts and
liabilities.
Majority Voting. The
holders of a majority of the outstanding shares of common stock constitute a quorum at any meeting of the shareholders. A plurality of
the votes cast at a meeting of shareholders elects our directors. The common stock does not have cumulative voting rights. Therefore,
the holders of a majority of the outstanding shares of common stock can elect all of our directors. In general, a majority of the votes
cast at a meeting of shareholders must authorize shareholder actions other than the election of directors. Most amendments to our articles
of incorporation require the vote of the holders of a majority of all outstanding voting shares.
Preferred Stock
Authority of Board of Directors to Create Series
and Fix Rights. Under our articles of incorporation, as amended, our board of directors can issue up to 100,000,000
shares of preferred stock from time to time in one or more series. The board of directors is authorized to fix by resolution as to any
series the designation and number of shares of the series, the voting rights, the dividend rights, the redemption price, the amount payable
upon liquidation or dissolution, the conversion rights, and any other designations, preferences or special rights or restrictions as
may be permitted by law. Unless the nature of a particular transaction and the rules of law applicable thereto require such approval,
our board of directors has the authority to issue these shares of preferred stock without shareholder approval.
Outstanding Warrants
As of September 15, 2021, the following warrants
were outstanding:
|
|
●
|
Warrants to purchase 10,000 shares of common stock at any time on or
prior to December 15, 2021 at an initial exercise price of $1.50 per share.
|
|
|
●
|
Warrants to purchase 6,667 shares of common stock at any time
on or prior to November 9, 2021 at an initial exercise price of $1.50 per share.
|
|
|
●
|
Warrants to purchase 33,334 shares of common stock at any time
on or prior to September 26, 2022 at an initial exercise price of $3.00 per share.
|
|
|
●
|
Warrants to purchase 33,342 shares of common stock at any time on or
prior to April 12, 2025 at an initial exercise price of $3.60 per share.
|
|
|
●
|
Warrants to purchase 62,172 shares of common stock at any time
on or prior to April 29, 2025 at an initial exercise price of $2.97 per share.
|
|
|
●
|
Warrants to purchase 96,668 shares of common stock and remain
outstanding at any time on or prior to December 31, 2022 at an initial exercise price of
$3.00 per share.
|
|
|
●
|
Warrants to purchase 62,172 shares of common stock at any time
on or prior to April 29, 2025 at an initial exercise price of $2.97 per share.
|
|
|
●
|
Warrants to purchase 17,866 shares of common stock at any time
on or prior to August 20, 2025 at an initial exercise price of $8.40 per share.
|
|
|
●
|
Warrants to purchase 560,192 shares of common stock at any time
on or prior to July 6, 2025 at an initial exercise price of $0.15 per share for 315,689 of
the warrants and $0.72 per share for 244,503 of the warrants.
|
|
|
●
|
Warrants to purchase 8,000 shares of common stock at any time
on or prior to June 7, 2023 at an initial exercise price of $3.00 per share.
|
|
|
●
|
Warrants to purchase 100,000 shares of common stock at any time
on or prior to January 27, 2026 at an initial exercise price of $4.15 per share.
|
|
|
●
|
Warrants to purchase 7,185,290 shares of common stock at any
time on or prior to January 27, 2026 at an initial exercise price of $4.50 per share.
|
|
|
●
|
Warrants to purchase 154,216 shares of common stock and remain
outstanding at any time on or prior to January 22, 2026 at an initial exercise price of $5.1875
per share.
|
|
|
●
|
Warrants to purchase 198,776 shares of common stock and remain
outstanding at any time on or prior to February 13, 2026 at an initial exercise price of
$5.3125 per share
|
|
|
|
|
|
|
●
|
Warrants to purchase 1,820,000 shares of common stock and remain outstanding
at any time on or prior to May 27, 2026 at an initial exercise price of $3.00 per share.
|
|
|
|
|
|
|
●
|
Warrants to purchase 1,315,789 shares of common stock and remain outstanding
at any time on or prior to August 25, 2026 at an initial exercise price of $3.00 per share.
|
Pursuant to the terms of such warrants, the applicable
exercise price of such warrants is subject to adjustment in the event of stock splits, combinations or the like of our common stock.
Anti-Takeover Effects of Certain Provisions of Our Articles of
Incorporation, as Amended, and Our Bylaws
Provisions of our articles of incorporation, as
amended, and our bylaws could make it more difficult to acquire us by means of a merger, tender offer, proxy contest, open market purchases,
removal of incumbent directors and otherwise. These provisions, which are summarized below, are expected to discourage types of coercive
takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to first negotiate with us.
We believe that the benefits of increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited
proposal to acquire or restructure us outweigh the disadvantages of discouraging takeover or acquisition proposals because negotiation
of these proposals could result in an improvement of their terms.
Calling of Special Meetings of Stockholders. Our
bylaws provide that special meetings of the stockholders may be called only by the chief executive officer, if any, or the president
or the board of directors.
Removal of Directors; Vacancies. Our
bylaws provide that a director may be removed either for or without cause at any special meeting of stockholders by the affirmative vote
of at least two-thirds of the voting power of the issued and outstanding stock entitled to vote; provided, however, that notice of intention
to act upon such matter shall have been given in the notice calling such meeting.
Amendment of Bylaws. The
bylaws provide that the bylaws may be altered, amended or repealed at any meeting of the board of directors at which a quorum is present,
by the affirmative vote of a majority of the directors present at such meeting.
Preferred Stock. Our
articles of incorporation, as amended, authorize the issuance of up to 100,000,000 shares of preferred stock with such rights and preferences
as may be determined from time to time by our board of directors in their sole discretion. Our board of directors may, without stockholder
approval, issue series of preferred stock with dividends, liquidation, conversion, voting or other rights that could adversely affect
the voting power or other rights of the holders of our common stock.
Transfer Agent and Registrar
The transfer agent and registrar for our common stock is ClearTrust,
LLC. ClearTrust, LLC’s address is 16540 Pointe Village Drive, Suite 210, Lutz, FL 33558 and its telephone number is (813) 235-4490.
SELLING STOCKHOLDERS
The table below sets forth, as of September 20, 2021, the following
information regarding the Selling Stockholders:
|
|
●
|
the number of shares of common stock owned by the Selling Stockholders prior to this offering, without regard to any beneficial
ownership limitations contained in the Warrants;
|
|
|
●
|
the number of shares of common stock to be offered by the Selling Stockholders in this offering;
|
|
|
●
|
the number of shares of common stock to be owned by the Selling Stockholders assuming the sale of all of the shares of common
stock covered by this prospectus; and
|
|
|
●
|
the percentage of our issued and outstanding shares of common
stock to be owned by the Selling Stockholders assuming the sale of all of the shares of common
stock covered by this prospectus based on the number of shares of common stock issued and
outstanding as of September 20, 2021.
|
Except as described above, the number of
shares of common stock beneficially owned by the Selling Stockholders has been determined in accordance with Rule 13d-3 under the
Exchange Act and includes, for such purpose, shares of common stock that the Selling Stockholders have the right to acquire within 60
days of September 20, 2021.
The shares of common stock that may be
offered by the Selling Stockholders hereunder will be acquired by such Selling Stockholders upon the conversion or exercise by such
Selling Stockholders of the Notes or Warrants that are held by such Selling Stockholders and that were previously issued in private
transactions by our company. Descriptions of the private transactions in which we issued the Notes and the Warrants are set forth
under the caption “Issuance of Securities to Selling Shareholders.” Except as otherwise indicated, we believe the
Selling Shareholders have sole voting and investment power with respect to such shares of common stock.
All information with respect to the common
stock ownership of the Selling Stockholders has been furnished by or on behalf of the Selling Stockholders. We believe, based on
information supplied by the Selling Stockholders, that except as may otherwise be indicated in the footnotes to the table below,
each Selling Stockholder has sole voting and dispositive power with respect to the shares of common stock reported as beneficially
owned by it. Because the Selling Stockholders may sell some or all of the shares of common stock beneficially owned by them and
covered by this prospectus, and because there are currently no agreements, arrangements or understandings with respect to the sale
of any of the shares of common stock, no estimate can be given as to the number of shares of common stock available for resale
hereby that will be held by the Selling Stockholders upon termination of this offering. In addition, the Selling Stockholders may
have sold, transferred or otherwise disposed of, or may sell, transfer or otherwise dispose of, at any time and from time to time,
the shares of common stock it beneficially owns in transactions exempt from the registration requirements of the Securities Act
after the date on which it provided the information set forth in the table below. We have, therefore, assumed for the purposes of
the following table, that each Selling Stockholder will sell all of the shares of common stock owned beneficially by it that are
covered by this prospectus, but will not sell any other shares of common stock, if any, that it presently owns. No Selling
Stockholder has held any position or office, or has otherwise had a material relationship, with us or any of our subsidiaries within
the past three years other than as a result of the ownership of our shares of common stock or other securities.
|
|
|
Shares Owned Prior to
the Offering
|
|
|
Number of Shares
|
|
|
Shares Owned After
the Offering
|
|
|
Name
|
|
Number
|
|
|
Percent (1)
|
|
|
Offered
|
|
|
Number
|
|
|
Percent (1)
|
|
|
Entities affiliated with Lind(2)
|
|
3,809,859
|
|
|
4.9%
|
|
|
8,735,790
|
|
|
-
|
|
|
-
|
|
|
(1)
|
The percentages in the table have been calculated on the basis of treating as outstanding for a particular person, all shares of our capital stock outstanding on September 20, 2021. On September 20, 2021, there were 72,533,850 shares of our common stock outstanding. To calculate a stockholder’s percentage of beneficial ownership, we include in the numerator and denominator the common stock outstanding and all shares of our common stock issuable to that person in the event of the exercise of outstanding options and warrants that are exercisable within 60 days of September 20, 2021.
|
|
(2)
|
Jeff Easton is the managing member of The Lind Partners, LLC, which is the manager of the Lind Global Asset Management IV, LLC and Lind Global Fund II LP (the “Lind Entities”), and has sole voting control and investment discretion over the securities held by the Lind Entities. Mr. Easton disclaims beneficial ownership over the securities listed except to the extent of his pecuniary interest therein. The principal business address of the Lind Entities is 444 Madison Ave, 41st Floor, New York, NY 10022.
|
|
(3)
|
The number of shares beneficially owned is based on 3,135,789 shares of common stock issuable upon exercise of the Warrants plus 674,070 shares of common stock issuable upon the conversion of the initial principal and interest payments on the Notes assuming the initial payment date for principal and interest on the Notes is October 1, 2021 and the conversion price per share on such date is $1.56, which is the conversion price for the payment of principal and interest assuming a calculation date of September 20, 2021. The actual number of shares issuable upon the conversion of the initial principal and interest payments on the Notes will be higher or lower depending on the actual initial payment date and the actual conversion price for such payments on such payment date. The beneficial ownership reflected in the table is subject to a beneficial ownership limitation of 4.99%, which does not permit the holders to convert or exercise any portion of the Notes or the Warrants, respectively, that would cause the holders to own, after conversion or exercise, as applicable, a number of shares of our common stock in excess of the beneficial ownership limitation. The amounts and percentages in the table give effect to the beneficial ownership limitation.
|
PLAN OF DISTRIBUTION
The Selling Shareholders and any of their pledgees,
donees, assignees and successors-in-interest may, from time to time, sell any or all of its shares of common stock being offered under
this prospectus on any stock exchange, market or trading facility on which our common stock is traded or in private transactions. These
sales may be at fixed or negotiated prices. The Selling Stockholders may use any one or more of the following methods when disposing
of the shares of common stock:
|
|
●
|
ordinary brokerage transactions and transactions in which the
broker-dealer solicits purchasers;
|
|
|
●
|
block trades in which the broker-dealer will attempt to sell
the shares as agent but may position and resell a portion of the block as principal to facilitate
the transaction;
|
|
|
●
|
purchases by a broker-dealer as principal and resales by the
broker-dealer for its account;
|
|
|
●
|
an exchange distribution in accordance with the rules of the
applicable exchange;
|
|
|
●
|
privately negotiated transactions;
|
|
|
●
|
to cover short sales made after the date that the registration
statement of which this prospectus is a part is declared effective by the SEC;
|
|
|
●
|
broker-dealers may agree with the Selling Stockholders to sell
a specified number of such shares at a stipulated price per share;
|
|
|
●
|
a combination of any of these methods of sale; and
|
|
|
●
|
any other method permitted pursuant to applicable law.
|
The shares may also be sold under Rule 144 under
the Securities Act, or any other exemption from registration under the Securities Act, if available for a Selling Stockholder, rather
than under this prospectus. Each Selling Stockholder has the sole and absolute discretion not to accept any purchase offer or make any
sale of shares if it deems the purchase price to be unsatisfactory at any particular time.
The Selling Stockholders may pledge their shares
of common stock to their brokers under the margin provisions of customer agreements. If a Selling Stockholder defaults on a margin loan,
the broker may, from time to time, offer and sell the pledged shares.
Broker-dealers engaged by a Selling Stockholder
may arrange for other broker-dealers to participate in sales. Broker-dealers may receive commissions or discounts from a Selling Stockholder
(or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in amounts to be negotiated, which commissions
as to a particular broker or dealer may be in excess of customary commissions to the extent permitted by applicable law.
If sales of shares offered under this prospectus
are made to broker-dealers as principals, we would be required to file a post-effective amendment to the registration statement of which
this prospectus is a part. In the post-effective amendment, we would be required to disclose the names of any participating broker-dealers
and the compensation arrangements relating to such sales.
The Selling Stockholders and any broker-dealers
or agents that are involved in selling the shares offered under this prospectus may be deemed to be “underwriters” within
the meaning of the Securities Act in connection with these sales. Commissions received by these broker-dealers or agents and any profit
on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Any
broker-dealers or agents that are deemed to be underwriters may not sell common shares offered under this prospectus unless and until
we set forth the names of the underwriters and the material details of their underwriting arrangements in a supplement to this prospectus
or, if required, in a replacement prospectus included in a post-effective amendment to the registration statement of which this prospectus
is a part.
The Selling Stockholders and any other persons
participating in the sale or distribution of the shares offered under this prospectus will be subject to applicable provisions of the
Exchange Act, and the rules and regulations under that act, including Regulation M. These provisions may restrict activities of, and limit
the timing of purchases and sales of any of the shares by, the Selling Stockholders or any other person. Furthermore, under Regulation
M, persons engaged in a distribution of securities are prohibited from simultaneously engaging in market making and other activities with
respect to those securities for a specified period of time prior to the commencement of such distributions, subject to specified exceptions
or exemptions. All of these limitations may affect the marketability of the shares.
If any of the shares offered for sale pursuant
to this prospectus are transferred other than pursuant to a sale under this prospectus, then subsequent holders could not use this prospectus
until a post-effective amendment or prospectus supplement is filed, naming such holders. We offer no assurance as to whether the Selling
Stockholder will sell all or any portion of the shares offered under this prospectus.
We agreed to use commercially reasonable efforts
to keep the registration statement of which this prospectus is a part effective at all times until the Selling Stockholders no longer
own any Warrants or shares of common stock issuable upon the exercise thereof. The shares will be sold only through registered or licensed
brokers or dealers if required under applicable state securities laws. In addition, in certain states, the shares of common stock covered
hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration
or qualification requirement is available and is complied with.
LEGAL MATTERS
The validity of the shares of
common stock and certain other matters of Nevada law will be passed upon for us by Flangas Law Group, Las Vegas, Nevada. Certain
matters of U.S. federal and New York State law will be passed upon for us by Pryor Cashman LLP, New York, New York.
EXPERTS
The financial statements incorporated by reference
into this prospectus as of December 31, 2020 and 2019 and for the year ended December 31, 2020 and the period January 10, 2019 (inception)
through December 31, 2019 have been audited by Haskell & White LLP, an independent registered public accounting firm, to the extent
and for the periods set forth in their report incorporated by reference herein and are included in reliance upon such report given upon
the authority of said firm as experts in auditing and accounting.
WHERE YOU CAN FIND MORE INFORMATION
We have filed with the SEC a registration statement
on Form S-3 under the Securities Act with respect to the securities being offered by this prospectus. This prospectus does not contain
all of the information in the registration statement of which this prospectus is a part and the exhibits to such registration statement.
For further information with respect to us and the securities offered by this prospectus, we refer you to the registration statement of
which this prospectus is a part and the exhibits to such registration statement. Statements contained in this prospectus as to the contents
of any contract or any other document are not necessarily complete, and in each instance, we refer you to the copy of the contract or
other document filed as an exhibit to the registration statement of which this prospectus is a part. Each of these statements is qualified
in all respects by this reference.
The registration statement of which this prospectus
is a part is available at the SEC’s website at http://www.sec.gov. You may also request a copy of these filings, at no cost,
by writing us at 5000 Quorum Drive, Suite 400, Dallas, Texas 75254, Attention: General Counsel or telephoning us at (469) 930-2661.
We are subject to the information and
reporting requirements of the Exchange Act and, in accordance with this law, file periodic reports, proxy statements and other
information with the SEC. These periodic reports, proxy statements and other information are available at the SEC’s website
referred to above. We also maintain a website at www.COMSovereign.com. You may access these materials free of charge as soon
as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained on our website
is not a part of this prospectus and the inclusion of our website address in this prospectus is an inactive textual reference
only.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The SEC allows us to “incorporate by reference” information
into this prospectus, which means that we can disclose important information to you by referring you to those documents and that the information
in this prospectus is not complete and you should read the information incorporated by reference for more detail. We incorporate by reference
in two ways. First, we list certain documents that we have already filed with the SEC. The information in these documents is considered
part of this prospectus. Second, the information in documents that we file with the SEC in the future will update and supersede the current
information in, and incorporated by reference in, this prospectus until we file a post-effective amendment that indicates the termination
of the offering of the common stock made by this prospectus.
We incorporate by reference the documents listed
below and any future filings we will make with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act (other than information
furnished in Current Reports on Form 8-K filed under Item 2.02 or 7.01 of such form unless such form expressly provides to the contrary),
including those made after the date of the initial filing of the registration statement of which this prospectus is a part and prior to
effectiveness of such registration statement:
|
|
●
|
our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on March 30, 2021;
|
|
|
●
|
our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2021 and June 30, 2021 filed with the SEC on May 17, 2021 and August 16, 2021, respectively;;
|
|
|
●
|
our Current Reports on Form 8-K, filed with the SEC on January 27, 2021, February 4, 2021, February 16, 2021, February 23, 2021, March 1, 2021, April 6, 2021, April 22, 2021, June 3, 2021, June 8, 2021, June 28, 2021, June 30, 2021, August 20, 2021 and August 30, 2021 (other than portions of those documents furnished or not otherwise deemed to be filed);
|
|
|
●
|
our definitive Proxy Statement on Schedule 14A for our 2021 Annual Meeting of Stockholders filed with the SEC on April 30, 2021; and
|
|
|
●
|
the description of our common stock contained in the registration statement on Form 8-A/A, dated December 22, 2020, File No. 001-39379,
and any other amendment or report filed for the purpose of updating such description.
|
The documents incorporated by reference into this
prospectus are also available on our corporate website at www.COMSovereign.com. We will provide to each person, including
any beneficial owner, to whom a prospectus is delivered, a copy of any or all of the information that has been incorporated by reference
in this prospectus but not delivered with this prospectus. You may request a copy of this information at no cost, by writing or telephoning
us at the following address or telephone number:
COMSovereign Holding Corp.
Attention: Corporate Secretary
5000 Quorum Drive, Suite 400
Dallas, TX 75254
469-930-2661
Attention: Kevin Sherlock, Esq.
Corporate Secretary
8,735,790
Shares
COMSovereign Holding Corp.
Common Stock
PROSPECTUS
,
2021
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14.
Other Expenses of Issuance and Distribution
The following table sets forth the expenses expected
to be incurred by us in connection with the issuance and distribution of the Securities registered hereby, all of which expenses, except
for the Securities and Exchange Commission registration fee, are estimates:
|
Description
|
|
|
Amount
|
|
|
SEC Filing Fee
|
|
$
|
1,620.22
|
|
|
Printing Expenses
|
|
|
500.00
|
|
|
Accounting Fees and Expenses
|
|
|
15,000.00
|
|
|
Legal Fees and Expenses
|
|
|
20,000.00
|
|
|
Miscellaneous
|
|
|
2,879.78
|
|
|
Total
|
|
$
|
40,000.00
|
|
Item 15.
Indemnification of Directors and Officers
Nevada Revised Statutes (“NRS”)
Section 78.7502 provides that a corporation shall indemnify any director, officer, employee or agent of a corporation against expenses,
including attorneys’ fees, actually and reasonably incurred by him in connection with any the defense to the extent that a director,
officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding
referred to Section 78.7502(1) or 78.7502(2), or in defense of any claim, issue or matter therein.
NRS 78.7502(1) provides that a corporation may
indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason
of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses,
including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection
with the action, suit or proceeding if he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner
which he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action
or proceeding, had no reasonable cause to believe his conduct was unlawful.
NRS Section 78.7502(2) provides that a corporation
may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit
by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director, officer,
employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent
of another corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and
attorneys’ fees actually and reasonably incurred by him in connection with the defense or settlement of the action or suit if he:
(a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner which he reasonably believed to be in or
not opposed to the best interests of the corporation. Indemnification may not be made for any claim, issue or matter as to which such
a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals there from, to be liable to the corporation
or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought
or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is
fairly and reasonably entitled to indemnity for such expenses as the court deems proper.
NRS Section 78.747 provides that except as
otherwise provided by specific statute, no director or officer of a corporation is individually liable for a debt or liability of the
corporation, unless the director or officer acts as the alter ego of the corporation. The court as a matter of law must determine the
question of whether a director or officer acts as the alter ego of a corporation.
Our Articles of Incorporation and Bylaws provide
that we shall indemnify our directors, officers, employees and agents to the full extent permitted by NRS, including in circumstances
in which indemnification is otherwise discretionary under such law.
These indemnification provisions may be sufficiently
broad to permit indemnification of our officers, directors and other corporate agents for liabilities (including reimbursement of expenses
incurred) arising under the Securities Act of 1933.
Insofar as indemnification for liabilities arising
under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of our company pursuant to the foregoing
provisions, or otherwise, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed
in the Securities Act of 1933 and is, therefore, unenforceable.
We have the power to purchase and maintain insurance
on behalf of any person who is or was one of our directors or officers, or is or was serving at our request as a director, officer, employee
or agent of another corporation, partnership, joint venture, trust or other business against any liability asserted against the person
or incurred by the person in any of these capacities, or arising out of the person’s fulfilling one of these capacities, and related
expenses, whether or not we would have the power to indemnify the person against the claim under the provisions of the NRS. We do not
currently maintain director and officer liability insurance on behalf of our director and officers; however, we intends to so purchase
and maintain such insurance when economically feasible.
Item 16. Exhibits and Financial Statement Schedules.
(a)
|
|
|
|
|
Incorporation
by Reference
|
Exhibit
Number
|
|
Exhibit Description
|
|
Form
|
|
Filing
Date
|
|
Exhibit
Number
|
|
4.1
|
|
Warrant dated April 29, 2020 issued to Red Diamond Partners LLC.
|
|
8-K
|
|
5/5/2020
|
|
4.2
|
|
4.2
|
|
Form of 9% Senior Convertible Debentures.
|
|
8-K
|
|
7/7/2020
|
|
4.1
|
|
4.3
|
|
Form of July 2020 Warrants to purchase common stock.
|
|
8-K
|
|
7/7/2020
|
|
4.2
|
|
4.4
|
|
Form of Warrant Agency Agreement dated January 26, 2021 between the Company and ClearTrust, LLC, including form of Warrant Certificate.
|
|
8-K
|
|
1/27/2021
|
|
10.1
|
|
4.5
|
|
Form of Convertible Note of COMSovereign Holding Corp. dated January 29, 2021.
|
|
8-K
|
|
2/4/2021
|
|
4.2
|
|
4.6
|
|
Senior Secured Convertible Promissory Note dated May 27, 2021 of COMSovereign Holding Corp. issued to Lind Global Asset Management IV, LLC.
|
|
8-K
|
|
6/3/2021
|
|
10.2
|
|
4.7
|
|
Warrant dated May 28, 2021 of COMSovereign Holding Corp. issued to Lind Global Asset Management IV, LLC.
|
|
8-K
|
|
6/3/2021
|
|
10.3
|
|
4.8
|
|
Convertible Promissory Note dated June 3, 2021 of COMSoverign Holding Corp. to Scott R Velazquez.
|
|
8-K
|
|
6/8/2021
|
|
10.2
|
|
4.9
|
|
Warrant
dated August 25, 2021 of COMSovereign Holding Corp. issued to Lind Global Fund II LP
|
|
8-K
|
|
8/30/2021
|
|
10.3
|
|
5.1
|
|
Legal Opinion of Flangas Law Group
|
|
—
|
|
*
|
|
—
|
|
23.1
|
|
Consent of Haskell & White.
|
|
—
|
|
*
|
|
—
|
|
23.2
|
|
Consent of Flangas Law Group (contained in Exhibit 5.1).
|
|
—
|
|
*
|
|
—
|
|
24.1
|
|
Power of Attorney (included on signature page)
|
|
|
|
|
|
|
Item 17. Undertakings
|
(a)
|
The undersigned registrant hereby undertakes:
|
|
|
(1)
|
To file, during any period
in which offers or sales are being made, a post-effective amendment to this registration statement:
|
|
|
(i)
|
to include any prospectus required
by Section 10(a)(3) of the Securities Act of 1933;
|
|
|
(ii)
|
to reflect in the prospectus
any facts or events arising after the effective date of the registration statement (or the most recent post- effective amendment thereof)
that, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of securities offered would not
exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected
in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent
no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee”
table in the effective registration statement; and
|
|
|
(iii)
|
to include any material information
with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information
in the registration statement;
|
provided, however,
that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii) above do not apply if the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13
or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained
in a form of prospectus filed pursuant to Rule 424(b) that is a part of the registration statement.
|
|
(2)
|
That, for the purpose of determining
any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide
offering thereof.
|
|
|
(3)
|
To remove from registration
by means of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering.
|
|
|
(4)
|
That, for the purpose of determining
liability under the Securities Act of 1933 to any purchaser:
|
|
|
(i)
|
each prospectus filed by the
registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was
deemed part of and included in the registration statement; and
|
|
|
(ii)
|
each prospectus required to
be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering
made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities
Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus
is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus.
As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be
deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that
prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided,
however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement
will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made
in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior
to such effective date.
|
|
|
(5)
|
That, for purposes of determining
any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of
the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the
Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating
to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
|
|
|
(i)
|
Insofar as indemnification
for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such
indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a
director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by
such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion
of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication
of such issue.
|
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly
authorized in the City of Dallas, State of Texas, on September 27, 2021.
|
|
COMSovereign Holding Corp.
|
|
|
|
|
|
By:
|
/s/ Daniel L. Hodges
|
|
|
|
Daniel L. Hodges
|
|
|
|
Chief Executive Officer
|
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person
whose signature appears below constitutes and appoints each of Daniel L. Hodges and Kevin Sherlock, his true and lawful attorney-in-fact
and agent, with full power of substitution and re-substitution, for him and his name, place and stead, in any and all capacities, to sign
any or all amendments (including pre-effective and post-effective amendments) to this registration statement, and to file the same, with
all exhibits thereto and other documents in connection therewith, including any Registration Statement filed pursuant to Rule 462(b) under
the Securities Act of 1933, with the SEC, granting unto said attorney-in-fact and agent, full power and authority to do and perform each
and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might
or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or any of his substitutes, may lawfully
do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities
Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
|
Name
|
|
Position
|
|
Date
|
|
|
|
|
|
|
|
/s/ Daniel L. Hodges
|
|
Chairman and Chief Executive Officer
|
|
September 27, 2021
|
|
Daniel L. Hodges
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
/s/ Martin R. Wade III
|
|
Chief Financial Officer
|
|
September 27, 2021
|
|
Martin R. Wade III
|
|
(Principal Financial and Accounting Officer)
|
|
|
|
|
|
|
|
|
|
/s/ John E. Howell
|
|
Director
|
|
September 27, 2021
|
|
John E. Howell
|
|
|
|
|
|
|
|
|
|
|
|
/s/ David Aguilar
|
|
Director
|
|
September 27, 2021
|
|
David Aguilar
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Richard J. Berman
|
|
Director
|
|
September 27, 2021
|
|
Richard J. Berman
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Brent M. Davies
|
|
Director
|
|
September 27, 2021
|
|
Brent M. Davies
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Kay Kapoor
|
|
Director
|
|
September 27, 2021
|
|
Kay Kapoor
|
|
|
|
|
|
|
|
|
|
|
|
/s/ James A. Marks
|
|
Director
|
|
September 27, 2021
|
|
James A. Marks
|
|
|
|
|
II-4
COMSovereign (CE) (USOTC:COMS)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
COMSovereign (CE) (USOTC:COMS)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
